Primmune Therapeutics

Home - Primmune

San Diego, United States · $61.7M raised

Business Model
B2B
Total Funding
$61.7M
Last Round
$23.3M Series BJan 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Primmune is a clinical-stage biotechnology company developing systemic cancer immunotherapies that activate the immune system in a precise and controlled manner. The company is advancing therapies designed to strengthen antitumor immunity, enhance the impact of existing treatments, and improve long-term disease control. Its lead investigational program, PRTX007, is an orally administered, systemically active small-molecule agonist of toll-like receptor 7 (TLR7) designed to activate plasmacytoid dendritic cells that coordinate innate and adaptive immune responses critical to effective cancer immunotherapy.

Summary

Primmune Therapeutics is a Biotech company based in San Diego, United States. It has raised $61.7M in total across 3 rounds, most recently a $23.3M Series B round in Jan 2026. Investors include Bioqube Ventures and OrbiMed.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2026
$23.3M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Primmune Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/primmune-therapeutics"><img src="https://indexed.vc/api/badge/company/primmune-therapeutics" alt="Primmune Therapeutics on Indexed.vc" width="260" height="76" /></a>